Invasive mould infections: a multi-disciplinary update

An Epidemiologic Update on Invasive Fungal Infections*

Aspergillus and Candida are the 2 major sources of invasive mycoses, and deaths due to these infections have been increasing overall during the past 2 decades. Antimicrobial resistance is an important concern, but the extent of resistance among fungi remains largely undefined. Assessing resistance patterns is essential to determine optimal treatment strategies. For invasive Candida infections, ...

Update on the Laboratory Diagnosis of Invasive Fungal Infections

Recent advances in the management of patients with haematological malignancies and transplant recipients have paralleled an increase in the incidence of fungal diseases due to pathogenic genera such as Candida and Aspergillus and the emergence of less common genera including Fusarium and Zygomycetes. Despite availability of new antifungal agents these opportunistic infections have high mortalit...

ISVH – A multi-disciplinary society

The International Society for Vascular Health (ISVH) was established in June 2005 as a non-profit making society under French Law (1901). Publication of ISVH bylaws and establishment of the Executive Committee were achieved in August 2005. The first question posed by the Board was: “Why yet another International Society?” The unanimous conclusion of the ISVH Board was that there exists an urgen...

Guidelines for the use of antifungal agents in the treatment of invasive Candida and mould infections.

ABSTRACT Treatment of invasive fungal infections is increasingly complex. Amphotericin B deoxycholate has long been the mainstay of treatment. However, there has been increasing recognition of both the propensity for nephro-toxicity in haematology, transplant and intensive care patients as well as its adverse impact on morbidity and mortality. This has coincided with the availabilty of newer, a...

update on zika virus infections